The latest: What they are saying: Intellectual property protections vital to COVID-19 research, development and manufacturing

Strong and reliable IP protections – including patents – have supported America’s robust innovation ecosystem by promoting discovery, development, affordability and access to new treatments and...
Read More
The latest: What they are saying: Intellectual property protections vital to incentivize ongoing COVID-19 research and development

America’s biopharmaceutical companies are committed to COVID-19 treatment and vaccine research and development (R&D). Reliable IP protections have helped drive innovation and enhance patient...
Read More
The latest: What they are saying: Intellectual property protections vital to incentivize ongoing COVID-19 research and development

America’s biopharmaceutical companies are committed to COVID-19 treatment and vaccine research and development (R&D). Reliable IP protections have helped drive innovation and enhance patient...
Read More
New video: See how strong IP protections lead to stronger treatments for patients

Intellectual property (IP) protections, including patents, are the foundation for biopharmaceutical innovation and the development of new treatments, cures and vaccines for patients. A strong IP...
Read More
The latest: What they are saying: Intellectual property protections vital to incentivize ongoing COVID-19 research and development

America’s biopharmaceutical companies are committed to COVID-19 treatment and vaccine research and development (R&D). Reliable IP protections have helped drive innovation and enhance patient...
Read More
Why the U.S. biopharmaceutical industry is leading the charge against COVID-19

The rapid spread and impact of COVID-19 has sparked a global race to find effective treatments and preventative vaccines with the U.S. biopharmaceutical industry leading the charge. America’s...
Read More
The latest: What they are saying: Intellectual property protections vital to incentivize ongoing COVID-19 research and development

America’s biopharmaceutical companies are committed to COVID-19 treatment and vaccine research and development (R&D). Reliable IP protections have helped drive innovation and enhance patient...
Read More
The latest: What they are saying: Intellectual property protections vital to incentivize ongoing COVID-19 research and development

America’s biopharmaceutical companies are committed to COVID-19 treatment and vaccine research and development (R&D). Reliable IP protections have helped drive innovation and enhance patient...
Read More
The latest: What they are saying: intellectual property protections critical as we work to defeat COVID-19

America’s biopharmaceutical companies are committed to COVID-19 treatment and vaccine research and development (R&D). Reliable IP protections have helped drive innovation and enhance patient...
Read More
The latest: What they are saying: Importance of intellectual property protections to combat COVID-19

America’s biopharmaceutical companies are committed to COVID-19 treatment and vaccine research and development (R&D). Reliable IP protections have helped drive innovation and enhance patient...
Read More